News and Announcements
Article highlight
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
Capital Insights
1
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
2
Following the Billions: Where the Hyperscalers are Betting on the Future
3
The Great Re-Allocation: Why AI is Forcing Smart Money From Software to Hard Science
4
AI is The Cheapest, Highest-Leverage Investment You Will Ever Make
Executive Interviews
Forging a $100M Future: Why Prime Financial Puts People First in its Acquisition Strategy
ASX-listed Prime Financial Group is on an ambitious path to a $100 million revenue target. Chairman Simon Madder reveals their playbook isn’t just about capital; it’s about a founder-focused acquisition strategy where cultural fit is the ultimate litmus test. Discover how their unique partnership model, which includes offering significant equity to incoming founders, is fuelling one of the sector’s most compelling growth stories.
Australia’s Trillion-Dollar Defence Tech Boom: A Call to Action for Founders
The global defence technology landscape is no longer a niche for the select few. For Australian founders, it represents a monumental, yet frequently underestimated, investment opportunity. Fuelled by escalating geopolitical tensions and a fundamental re-prioritisation of global spending, this sector is experiencing an unprecedented tailwind. According to Steve Baxter, Lead Investor at Beaten Zone Venture […]
IPO Bound: The Strategic Edge Guiding Australian Investors to India’s Next Unicorns
Uncover Creek Partners’ strategic vision for Australian investors in India’s booming economy. From IPO-bound deals to pioneering tech exchange, this playbook reveals how to navigate and profit from a market set to hit $7 trillion.
Capital Insights
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Company Updates
Wholesale Investor and MTPConnect Announce Strategic Partnership to Accelerate Investment in Australia’s Life Sciences Sector
Wholesale Investor and MTPConnect announce a landmark strategic partnership to bridge the funding gap in Australia’s life sciences sector. The collaboration creates a comprehensive capital engagement program, culminating in the Life Sciences Investor Day at the Emergence 2026 Conference
Steve Torso on Why Brevity Wins in Capital Raising
In the relentless pursuit of investment, founders often believe more information equates to more persuasion. However, according to Steve Torso, Co-founder and Managing Director at CapitalHQ and Wholesale Investor, the science of successful capital raising dictates a counter-intuitive approach: less is more, especially in the initial stages. “When you’re actually communicating your business, you’ve got […]
Wholesale Investor and CapitalHQ Sign Exclusive Master Licence with inQ Innovation Global to Provide Access to India’s High-Growth Startup Market
Wholesale Investor and inQ Innovation have forged a strategic partnership, granting global investors direct access to India’s rapidly expanding innovation ecosystem. This exclusive three-year agreement leverages CapitalHQ’s technology to streamline fundraising for Indian startups and expand deal flow for WI’s 45,000-strong investor network, aligning with India’s 2030 Vision for economic growth and innovation.
EBR Systems: Aussie Medtech Ready to Disrupt $3.6B Heart Failure Market with Leadless Pacemaker
Andrew Shute, Senior Vice President of Business Development at EBR Systems, is confident that his Australian medical device company is poised to make a significant impact on the global cardiac rhythm management market. The focus? A novel leadless pacemaker designed to revolutionise treatment for heart failure patients. After years of development and rigorous clinical trials, […]
Why Digital Assets Like Bitcoin Are Demanding Portfolio Attention
Edward Carroll, Edward Carroll, Head of Global Markets & Corporate Finance at MHC Digital Group, delivered a compelling message at the Emergence event: the era of dismissing digital assets as a mere speculative fad is definitively over. What was once a fringe movement, encompassing cryptocurrencies and broader blockchain-based technologies, has matured into an “unstoppable force” […]
Are Aussie Female Founders Being Left Behind?
Key Takeaways: Despite a vibrant early-stage ecosystem, Australian startups with female founders are encountering significant headwinds when it comes to securing larger, later-stage funding rounds, according to the latest “Cut Through Quarterly Q1 2025 Australian Startup Funding” report. The data reveals a concerning dip in the overall proportion of capital directed towards ventures with female […]
Venture Investor Interviews
Cryptos New Frontier: Institutionalisation, Real-World Assets, and the End of Wild West Investing
The cryptocurrency landscape, once characterised by rapid cycles and speculative frenzy, is undergoing a profound transformation. As global institutions and high-net-worth individuals increasingly look to allocate capital to digital assets, the focus is shifting towards maturity, regulatory clarity, and the integration of blockchain technology with traditional finance. A recent at the Emergence Singapore 2025 panel […]
Moving to Venture Investing 3.0
The next ten years are going to be the most disruptive – and potentially the most profitable – in the history of venture capital. Learn what technologies and techniques you need to adopt in order to become a successful, next-generation private market investor from this keynote presentation by Hatcher+ Managing Partner John Sharp. Looking for […]
Investing in DeepTech for the Non-Technical Investors
When investing in DeepTech, understanding how to analyse the financials of a business can only take you so far. It is the investors who are able to conduct technological analysis that perform best. This is sometimes out of reach for investors with a non-technical background. If you’re a non-technical investor, watch this panel session as […]
What You Need to Know about ESG Investing
ESG stands for Environmental, Social and Governance. It makes up for factors that form part of any new or existing venture analysis. Investors are increasingly considering these factors as part of their analysis, especially on the institutional/VC side. Because of this, it is important to have a grasp on what exactly ESG entails, and how […]
Venture Investing in a Recession
Public markets are correcting, VC money is drying up and investors are as prudent as ever. Surrounded by these signs of a depressed market, investors in the process of deploying capital may need to change their methods of analysis and deal structure in order to ensure proper entry prices. Watch this panel session as seasoned […]
This Mobile Health Education App Aims to Address Nurses Shortage, Skills Gap in Africa
By 2030, there is a projected shortfall of 1.4 million nurses in Africa. Yangama Jokwiro, Director & Senior Lecturer at VAKA Health Foundation & La Trobe University, has developed a mobile health education app to help close this skill gap so nurses in under-resourced contacts can provide the best care possible. At present, almost 30,000 […]
Backed By Leading Investment Groups and Family Offices
